MedPath

The EXPLORE MG Registry for Myasthenia Gravis

Recruiting
Conditions
Myasthenia Gravis
Registration Number
NCT03792659
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Detailed Description

This registry will allow for the research of several mechanisms of Myasthenia Gravis (MG) by studying peripheral blood, stool, disease status and course, and treatment of subjects with MG. The EXPLORE-MG Registry focuses on varied aspects of MG such as disease management, health care utilization, health costs, disease characteristics, and diagnostic tools. As such, it will aid in a broader understanding of MG, while providing a registry from which questions about the disease may be better answered.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
800
Inclusion Criteria
  • Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.
Exclusion Criteria
  • Failure to meet the Inclusion Criteria.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of successful blood draws will be reported at the conclusion of the sample collection8 years

Successful Collection of Blood

Secondary Outcome Measures
NameTimeMethod
The number of stool samples collected will be reported at the conclusion of the sample8 years

Count of Stool Samples

Trial Locations

Locations (1)

Yale-New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Yale-New Haven Hospital
🇺🇸New Haven, Connecticut, United States
Bailey Munro Sheldon, PhD
Contact
203-737-7095
bailey.munrosheldon@yale.edu
Richard Nowak, MD, MS
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.